BBOT BridgeBio Oncology Therapeutics, Inc.

NASDAQ

$3.94

BridgeBio Oncology Therapeutics, Inc. (BBOT) Earnings News

Earnings press releases, previews and reviews for BridgeBio Oncology Therapeutics, Inc. (BBOT), newest first.

Tuesday August 11, 2026 4:05 PM ET

BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

Tuesday May 12, 2026 5:03 PM ET

BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress